Chloroquine excretion following malaria prophylaxis.
Urinary excretion of chloroquine and its desethyl-metabolite was monitored for up to 395 days after the last dose of oral chloroquine (300 mg base) taken once weekly for 10 weeks as malaria prophylaxis. Concentrations in plasma could be followed for up to 70 days after the last dose. A three exponential decay was applied to the urinary excretion data. The half-life of the terminal phase varied from 45 to 55 days for chloroquine and from 59 to 67 days for the metabolite. Mean residence time was approximately 20 days for the parent compound and 35 days for the metabolite, indicating that the terminal phases are of less importance for the effective half-lives.
D000328:Adult; D002738:Chloroquine / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use / Q000652:urine*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008297:Male
D002738:Chloroquine; C007278:desethylchloroquine